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INTRODUCTION 1
During the last decades there has been increasing interest in the fatty acid composition of 2 infant formulas (1, 2) . The interest has focused on the content of polyunsaturated fatty acids 3 (PUFA), especially the balance between n-3 and n-6 PUFA and the possible need to add the 4 long-chain PUFA (LCPUFA), docosahexaenoic acid (22:6n-3, DHA) and arachidonic acid 5 (20:4n-6, ARA). Recently, the importance of the stereospecific triacylglycerol structures has 6 been demonstrated (3, 4) . The target has been to produce an infant formula with a fat content, 7 composition and structure close to that found in human milk. Using a blend of different fats, 8 mainly vegetable oils, it has been possible to match the overall fatty acid composition of 9 human milk, but not the triacylglycerol structure. 10
Fat absorption is higher from human milk than from infant formula, despite the 11 similarities between the fatty acid profiles (5). This may partly be explained by the unique 12 triacylglycerol structure of human milk. Palmitic acid (16:0) is abundant in human milk and 13 is an important source of energy. Most of the 16:0 in human milk is located in the sn2-14 position of the triacylglycerol molecules (6), in contrast to cow's milk and vegetable oils 15 which have 40 % (7) and 5-20 %, respectively, of the 16:0 in the sn2-position (8). Therefore, 16 hydrolysis of human milk fat result in 16:0 mainly as sn2-monoacylglycerol, which are well 17 absorbed (7, 9) . In contrast, after hydrolysis 16:0 from vegetable oils will be present as free 18 fatty acids, which tend to bind calcium and form insoluble calcium-soaps in the intestine that 19 may cause constipation 20 LCPUFA are present in human milk but have not until now been added to the 21 majority of standard infant formulas avialable in the Danish market. DHA is important for 22 development of the nervous system (2) and ARA is the precursor of eicosanoids (10), which 23 are local mediators involved in, for example, the regulation of the immune function and 24 platelet aggregation. It is presently recommended that the content of the precursors for these 25 4 LCPUFA, linoleic acid (18:2n-6, LA) and α-linolenic acid (18:3n-3, LNA), are 500-1200 1 mg/100 kcal and above 50 mg/100 kcal, respectively, to the infant formulas without 2 LCPUFA and that the ratio of LA to LNA should be between 5 and 15 (11). It is generally 3 agreed that LCPUFA should be added to formulas for preterm infants, whereas no agreement 4 has been reached on whether to add LCPUFA to formulas for term infants (11, 12, 13) . 5
The aim of this study was to describe the fatty acid compositions and the 6 stereospecific triacylglycerol structures of a selection of formulas in the market in Denmark, 7 to compare these with human milk, when appropriate, and to discuss some of the 8 consequences of these issues. Our focus was on the content and position in the 9 triacylglycerols of 16:0, oleic acid (18:1n-9), LA, LNA, DHA and ARA. Furthermore, we 10 studied structure and profile differences of the fat from formulas with different applications 11 (for premature, term infants or infants with various disorders), with special focus on the 12 presence of medium-chain fatty acids (MCFA, 8:0 and 10:0). 13
14

MATERIALS AND METHODS 15
Twenty-eight different formulas were analyzed. Five of the formulas were for premature 16 infants; eight for term newborn infants (term infant formulas), four were follow-on formulas 17 for infants >4 mo of age, and 11 were special formulas for infants and young children with 18 different disorders ( Table 1 ). The fatty acid profiles and structures were compared to values 19 from different types of human milk. We analysed a pooled sample of human milk derived 20 from mothers delivering prematurely before the gestational age of 34 weeks. The mothers 21 emptied both breasts with the help of an electrical pump and each mother collected the milk 22 in a 24 hour pool. The milk was collected between the second and fourth week after delivery. 23 Furthermore, we included in Table 3 sets of values from the literature (6, 9, 14) . We also 24 analysed cow's milk (standard full fat pasteurized cow's milk bought during the month of 1 February). 2
The formulas were purchased and analyzed between 1999-2003. Seven of the 3 formulas were purchased and analyzed both in 2003 (Allomin-1, Allomin-2, 4 soured Allomin, Baby Milk, Enfalac, Nutramigen and NAN H.A). These analyses gave 5 similar results with respect to profile and structure for all except one of the formulas. In 2003 6 Enfalac had increased proportions of 18:1n-9, ARA and DHA and decreased proportions of 7 lauric acid (12:0) and LA compared to that in the 1999 formula. This paper presents the 8 results of the most recent analyses. 9 10 Formula fat analysis 11 Powdered formulas were dissolved in water (250 mg formula/ml water), whereas liquid 12 formulas, human milk and cow's milk were extracted from their origin. The fats were 13 extracted by the Folch procedure (15) and fatty acids were dissolved in heptane. Fatty acid 14 methyl esters (FAME) were prepared from total lipids through transesterification catalysed 15 by KOH in methanol (16). The FAME were analysed by gas-liquid chromatography using a 16
Hewlett-Packard 5890 series II Chromatograph with flame-ionisation detection Packard GmbH, Waldbronn, Germany), and a fused silica capillary column (SP-2380, 60 m, 18 ID 0.25 mm, Supelco, Bellefonte, PA). Helium was used as carrier gas. A split ratio of 1:11 19 was applied in the injector. The column flow was constant at 1.2 mL/min. Initial oven 20 temperature was 70 o C for 0.5 min and temperature programming was as follows: 15 o C/min 21 to 160 o C, 1.5 o C/min to 200 o C, which was maintained for 15 min followed by a rate of 30 22 o C/min to 225 o C, which was then maintained for 5 min. FAME peaks in the chromatogram 23 (from octanoic acid (8:0) to DHA (from 4:0 for cow´s milk)) were identified from external 24 6 standards (Nu-Chek-Prep, Inc. Minnisota, USA). The chromatogram areas of FAME with 1 fewer than 12 carbons were corrected by response factors. 2 Regiospecific analyses of the formula fats were performed by degradation of the 3 triacylglycerol molecules with allylmagnesium bromide as Grignard reagent (17 The fatty acid profiles and the sn2-fatty acids of the analysed infant formulas were 18 compared with that of a range of human milk values and cow's milk (Table 2-4). Values 19 market in bold are higher than the range found in human milk and values market in italic are 20 lower. In general, the content of 18:1n-9, LA and LNA were higher in the infant formulas 21 than in human milk both in total fatty acids and in the sn2-position. The content of MCFA 22 was more than 20 fold higher than in human milk in six of the formulas: two preterm, two 23 for use in malabsorption, and two for use as energy supplement. DHA was detected in seven 24 7 out of the 28 formulas, and in the sn2-position of two, whereas ARA was detected in eight 1 formulas and in the sn2-position of six. 2
The ratios of LA to LNA in all of the formulas and cow's milk were within the 3 interval recommended for standard infant formula of 5:1 to 15:1 (Tables 2-4), except  4 Pregestimil, Super Soluble Duocal, Generaid Plus, Neocate and Therapeutic milk (all special 5 formulas), which all had ratios >15:1. The proportions of LA in preterm infant formulas were 6 about twice that in human milk, whereas that of LNA was similar to or twice that in human 7 milk, resulting in LA-to-LNA-ratios that in most of the formulas were higher than in human 8 milk. 9 10 DISCUSSION 11
Most infant formula fats are based on mixtures of vegetable oils or a blend of cow's milk fat 12 and vegetable oils that to some extent mimic the fatty acid profile of human milk, as observed 13 in the present study. However, the stereospecific structure in the formulas differed 14 considerably from that in human milk. Most (about 75 %) of the 16:0 in human milk was 15 located in the sn2-position, whereas most of the 16:0 in the formulas was located in the outer 16 positions of the triacylglycerols (75-97 %). Comparison of infant formulas and human milk 17 showed that 18:1n-9 replaced 16:0 in the sn2-position, as in vegetable oils (e.g. rapeseed and 18 palm oils). This indicates that the largest part of the fat used in the formulas was of vegetable 19 origin, except for Baby Milk, which was primarily based on cow's milk fat. 20
The human milk values we have used for comparison show a quite constant fatty acid 21 pattern, despite the types of human milk being quite different (preterm milk, colostrums and 22 mature milk). As expected the largest variation was in the content of DHA which is highly 23 dependant on the mothers intake of DHA (19) . 24 8 Constipation is more often observed in formula fed infants than in breast-fed infants 1 (20) . The structure differences between infant formula fats and human milk is one of the 2 major reasons for the formation of insoluble calcium-soaps in the intestine. Betapol (Loders 3 Croklaan, Wormerveer, The Netherlands) is a synthetic fat produced to mimic human milk 4 fat both in total fatty acid profile and in structure (45 % of the 16:0 in the sn2-position). 5
Studies with Betapol and other structured human milk substitutes showed that fats rich in 6 sn2-16:0 compared to fats with a lower proportion of the 16:0 in the sn2-position improved 7 absorption of 16:0 and calcium and reduced the excretion of calcium-soaps in the faeces of 8 preterm infants (3), term infants (4) and rats (21). These studies support a beneficial 9 physiological effect of the specific structured triacylglycerols on fat and calcium absorption. 10 However, problems with calcium soap formation can also be solved by substituting 16:0 with 11 other fatty acids, e.g. 18:1n-9, as in many of the infant formulas, or with medium chain fatty 12 acids (MCFA.). 13
High proportions of MCFA were found in special formulas for infants with 14 malabsorption, lymphatic disorders, renal disease, liver disease (Pregestimil, Monogen, Super 15 Soluble Duocal and Generaid Plus), and for preterm infants (PreNAN, Enfalac). These were 16 added primarily instead of 16:0 as a readily available energy source. Infants with 17 malabsorption can easier degrade, absorb and transport MCFAs than fatty acids of longer 18 chain length. MCFAs are absorbed mainly to the portal vein and transported directly to the 19 liver for β-oxidation (22). Formation of insoluble calcium-soaps in the intestine is low to 20 non-existing, when MCFAs replace 16:0, due to the higher absorption (23,24). The 21 nutritional value of special formulas with a high content of MCFA may be increased by 22 addition of LCPUFA, possibly even further if the fat is structured (3). LCPUFA absorption 23 has been shown to be improved in rats with malabsorption, if LCPUFA is supplied in fat with 24 9 MCFA in the outer positions and LCPUFA in the sn2-position (25,26) and so have fat 1 utilisation and nitrogen retention in piglets (27). 2
The LA and LNA content of infant formulas are believed to cover the need of n-6 and 3 n-3 LCPUFA in term infants through elongation and desaturation to ARA and DHA. 4 According to the current Nordic recommendations for infants 6-11 months of age the dietary 5 intake of n-6 and n-3 PUFA should supply at least 4.0 % and 1.0 % of the energy intake, 6 respectively (28). Since the fat content of breast-milk and formulas constitutes about 50 % of 7 the energy, this is equivalent to a n-6 and n-3 PUFA content of approximately 8 and 2 wt%, 8 respectively. Only four of the formulas in our study were found to have LNA content of 9 around 2 wt%. The ESPGHAN Committee on Nutrition (29) and the Scientific Committee on 10 Food (15) recommend that the ratio of LA to LNA in infant formulas should be 5-15. This 11 recommendation was made in the absence of data on functional or clinical outcomes (30). 12
Lowering the ratio of LA to LNA from 10:1 to 5:1 in formula fats resulted in modest increase 13 in plasma DHA, but with no detectable effect on visual acuity or growth rate (30). Most of 14 the formulas were found to have a high LA content well above that in human milk. A few of 15 the formulas, mostly special formulas intended for infants with special needs, had a very high 16 content of LA and ratios of LA to LNA between 17-55:1. Recent studies indicate that DHA 17 formation is inhibited by a high supply of LA (31,32). Therefore, there may be a need to 18 decrease the LA content, or supply LCPUFA, in order to meet the n-3 LCPUFA needs in 19 infants. However, the ratio of LA to LNA in infant formulas has improved since we analysed 20 infant formulas in the Danish market in the mid 1990s (33). 21
Only seven of the 28 infant formulas contained DHA and only eight of them had 22 ARA. In human milk 55 % of DHA was found to be specifically located in the sn2-position 23 of the triacylglycerol. Of the seven infant formulas that contained DHA, only PreNAN and 24
Enfalac had high levels in the sn2-position (34-50 %). Preterm infants have significantly 25 10 lower ARA and DHA status than full-term infants, because they do not receive the 1 intrauterine supply of these fatty acids during late pregnancy (34). Dietary deficiency of ARA 2 and DHA has therefore become an issue for the nutrition of preterm infants. Our results 3 showed that the contents of these fatty acids in the formulas were similar to or lower than in 4 human milk in four out of five formulas for ARA, and in all the preterm formulas for DHA. 5
However, compared to other countries Danish mothers have a high n-3 LCPUFA intake and, 6 thus, high levels of DHA in their milk (2). 7
The ratio of LA to LNA and the presence of LCPUFA in some of the formulas 8 demonstrate that an improvement of the fatty acid profiles of the infant formulas has taken 9 place over the last decades, although the content of LNA is still low and that of LA high 10 compared to current recommendations and compared to the content in human milk from 11
Danish mothers. In the present study the structure analyses of the formulas showed that there 12 was a discrepancy between the locations of the fatty acids in formula fats compared with that 13 in human milk. In contrast to human milk, 16:0 in infant formulas was located primarily in 14 the outer positions of the triacylglycerol molecules, which may increase the risk of 
a Data represent the average of two determinations for triacylglycerols and 3-4 determinations of the sn2-position and are expressed in wt% of total fatty acids in triacylglycerol or the sn2-position, respectively. b Fatty acids are designated by the number of carbon atoms followed by the number of double bonds. The position of the first double bond relative to the methyl (n) end of the molecule is also indicated. Values in bold are higher than for human milk and values in italic are lower. Table   Table 1 .
List of infant formulas and foods for special medical purpose, the year they were purchased, manufacturer and type and indications for special medical foods.
